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PATHOPHYSIOLOGY AND TREATMENT OF THE OVERACTIVE 
BLADDER SYNDROME IN AN AGED MALE PATIENT WITH 
VOIDING DIFFICULTY: PHARMACOLOGICAL TREATMENT 
Hironobu AKINO 
The Department 01 Urology， School 01 Medicine， University 01 Fukui 
Pharmacolgical treatment is the main stay in the treatment of overactive bladder (OAB). 
However， it can be difficult to treat the patients with OAB and voiding difficulty. The present patient 
was a 75・year-oldmale， who had wet OAB and voiding difficulty with slight enlargement ofthe prostate 
( ultrasound幽estimatedprostate volume; 28 ml) and a medical history of cerebral infarction. The 
analysis of clinical data gained from the patients with lower urinary tract symptoms in our institution 
suggested that the etiology ofOAB in this patient was neurogenic bladder with high probability (nearly 
80%)， and the probability of the existence of bladder outlet obstruction (BOO) was approximately 
40 %. Given the high probability of the neurogenic OAB， the first-line therapy should be a 
pharmacological treatment. If he had BOO， the treatment should start with alpha-adrenoceptor 
blockers， and also the combination of anticholinergic drugs and alpha-blockers would be beneficial. If 
he had impaired detrusor contractility， we have no evidence-based proposal for his treatment. 
(Hinyokika Kiyo 51 : 609-613， 2005) 
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score of urgency 
The score of urgency in the international prostate symptom score was ass_o~iated 
with age and p;ost~te volume in male patients aged 50 years or over with lower 
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(nニ21) (18) (15) (11) (13) 
prostate volume (凶) (Pearson's test， p=0.0005) 
Fig. 2. The prevalence ofurgency in male LUTS patients aged 70 years or over according 
to their prostate volumes. The prevalence ofsevere urgency (score of3 to 5) was 
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prostate volume (ml) (Pearson's test， p=O.OOOl) 
Fig. 3. The prevalence of bladder outlet obstruction (ultrasound-estimated bladder 
wei~h! _of 35 g or more) ~~cording to the prostate volume in male L UTS patients 
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prostate volume (ml) (Pe釘'Son'stest， p=0.0147) 





































(sli喧htor皿oderatedegree of Bゆoand PVR of 150ml or lesl 
UDS 
α1-blocker x 3 months 
effective r一一」一一一寸non-effective
60(79%) 1 1 16(21%) 
α-block位 11α-blocker+ 
tolterodine 
|effective 6 (37%) I 
effective r一.......J...一一一寸non-effective
24(35%) 1 1 44(65%) 













Fig. 5. The treatment outcome of doxazosin with or without tolterodine in men with 
symptomatic bladder outlet obstruction and overactive bladder (From Lee JY， et
al.) BJU Int 94: 817-820， 2004 



























detrusor hyperactivity with impaired contractility 
(DHIC)である.DHICの治療に関する randomized




































亡コ thed町叫ionof being tr叫 edwithα1もl叫 :er




Five out of 6 patient温treatedwith TURP had a pharmacological 
medication for LUTS postoperatively 
(n=6) 
O 20 40 60 
follow.up duration (months) 
Fig. 6. The treatment modality and its duration in each patient with urgency and lower 
urinary tract disorder like detrusor hyperactivity with impaired contractility. 
All patients in this figure complained of urgency with poor uroflow (maximum 
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